Kiora Pharmaceuticals, Inc. - Common Stock KPRX 深 滬
等待開盤 08-22 09:30:00 美东时间
2.66
+0.010
+0.38%
華盛通- 最 高2.66
- 今 開2.59
- 成交量 2.71万股
- 最 低 2.55
- 昨 收 2.65
- 總市值 809.68万
- 52周最高 4.18
- 市盈率 靜 3.05
- 換手率 0.89%
- 52周最低 2.25
- 委 比 97.04%
- 總股本 304.39万
- 歷史最高 189000.00
- 量 比 0.32
- 振 幅 4.15%
- 歷史最低 2.25
- 每 手 1
- 風險率 0.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kiora Pharmaceuticals GAAP EPS of -$0.54
Kiora Pharmaceuticals press release (NASDAQ:KPRX): Q2 GAAP EPS of -$0.54. Ended the quarter with $20.7 million in cash, cash equivalents and short-term investments, along with $2.4 million in collabor...
08-08 19:09
Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection For KIO-104 In The Treatment of Ocular Disease
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but is not limited to,
07-22 21:09
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
Kiora Pharmaceuticals ( ($KPRX) ) has issued an announcement. On June 4, 2025, ...
06-05 02:57
Kiora Grants Senju Option to Develop and Market Vision-Restoring Drug KIO-301 in Asia
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company") today announced it has granted Senju Pharmaceutical Co., Ltd. (Senju) an exclusive option to exercise rights to an exclusive development and
06-03 19:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers BioSig Technologies (NASDAQ:BSGM) stock moved upwards by 18.9% to $0.6...
04-17 05:05
美股大行评级 | 潜在涨幅686.94%！Sensei Biotherapeutics获Oppenheimer升目标价至4美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级，目标价从3.5美元升至4美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
Kiora Pharmaceuticals, Inc. ( ($KPRX) ) has released its Q4 earnings. Here is a...
03-26 11:55
Kiora Pharmaceuticals Gains Approval for Phase 2 Trial
Kiora Pharmaceuticals ( ($KPRX) ) has issued an update. Kiora Pharmaceuticals h...
2024-10-29 19:28
HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price target.
2024-08-23 00:28
